Burrill Life Sciences Capital Fund III, L.P. (Active)

Burrill & Company is the general partner of the Burrill Life Sciences Capital Fund III, L.P. (the "Fund"). This Fund is the sixth in a series of Burrill venture capital funds and invests exclusively across the entire spectrum of life sciences, including biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, wellness and nutraceuticals, agbio, and industrial biotechnology (biomaterials/bioprocess). The Fund operates as a "best of breed" investment fund, selecting only investments in companies that are believed to be the best of their class and those likely to deliver the highest returns on invested capital. The Fund is diversified as to stage of investment and life sciences sub-sector. This fund closed in 2006 and is capitalized at $283 million.

Current Activity Level: Active investor(invests $1 million to $20 million per company)
Geographic Preferences: Global